Pricing Log in Create free account

Biora Therapeutics, Inc. (BIORQ) vs HCW Biologics Inc. (HCWB)

Biora Therapeutics, Inc. and HCW Biologics Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and HCW Biologics Inc. are of similar size ($2.5M and $2.3M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against 347.0%. HCW Biologics Inc. has the higher net margin (−329.4% vs −3,527.9%) and the lower return on invested capital (−36.2% vs 0.00%). Across the 15 metrics below, HCW Biologics Inc. leads on 9 and Biora Therapeutics, Inc. on 6.

Valuation

Metric BIORQ HCWB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.20 9.40
P/B n/m 0.18 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 67.44 1.12 9.02
Earnings yield 0.00% (2,786.94%) (32.88%)
Free cash flow yield 0.00% (915.31%) (23.13%)

Profitability

Metric BIORQ HCWB Biotechnology median
Gross margin 85.79% 95.91% 68.51%
Operating margin (6,809.06%) (114.02%) 0.00%
Net margin (3,527.85%) (329.38%) 0.00%
Free cash flow margin (5,165.88%) (180.57%) 0.00%
Return on equity 27.98% (600.32%) (51.96%)
Return on assets (128.19%) (79.52%) (46.06%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric BIORQ HCWB Biotechnology median
Revenue growth (TTM) 347.00% 706.96% 6.76%
EPS growth (last fiscal year) (57.40%) 65.49% 29.88%
Revenue growth, 5-year CAGR (87.44%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ HCWB Biotechnology median
Debt to equity (0.18) 0.88 0.00
Current ratio 0.05 0.06 4.97
Net debt to EBITDA (0.47) (0.40) 1.01

Dividend

Metric BIORQ HCWB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIORQ HCWB Biotechnology median
Market cap 2.49m 2.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack